Lisdexamfetamine Dimesylate 31722-0351-01
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 9, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA217442
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
31722-0351-01Selected100 CAPSULE in 1 BOTTLE (31722-351-01)